The global in vivo toxicology market is anticipated to grow at a considerable CAGR of over 4% during the forecast period (2021-2027). The increasing number of preclinical trials of drugs and therapies of various diseases including cancer, and arthritis are boosting the market growth of in vivo toxicology.
However, the introduction of the 3Rs testing method will restrain the market growth which includes reduce, refine, and replace the use of animal models. These principles were introduced by WMS Russell and RL Burch in their scientific article- The Principles of Humane Experimental Techniques, published in 1959.
A full report of In Vivo Toxicology Market is available at: https://www.omrglobal.com/industry-reports/in-vivo-toxicology-market
The market players are contributing considerably to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, Danaher Corp. in March 2020 had acquired the life sciences division of General Electric Co. which was named Cytiva.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered-
o By Type
o By Toxicity End Point
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape-Agilent Technologies, Inc., Charles River Laboratories, Danaher Corp., Ingenious Targeting Laboratory, Merck KGaA, Thermo Fisher Scientific, Inc.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/in-vivo-toxicology-market
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global In Vivo Toxicology Market Report Segment
By Type
- Acute
- Sub-acute
- Sub-chronic
- Chronic Test Type
By Toxicity End Point
- Immunotoxicity
- Systemic Toxicity
- Carcinogenicity
- Genotoxicity
- Development & Reproductive Toxicity (DART)
- Others
This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.
